These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25423929)

  • 1. [New Developments in CKD-MBD. Efficacy and safety of antiosteoporotic agents in CKD].
    Kazama JJ
    Clin Calcium; 2014 Dec; 24(12):1831-7. PubMed ID: 25423929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New Developments in CKD-MBD. Bone quality and fracture in patients with chronic kidney disease].
    Iwasaki Y; Yamato H
    Clin Calcium; 2014 Dec; 24(12):1809-14. PubMed ID: 25423926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractures in chronic kidney disease: pursuing the best screening and management.
    Goldenstein PT; Jamal SA; Moysés RM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paricalcitol and cardiorenal outcome: from the IMPACT study to clinical practice.
    Bellasi A; Galassi A; Salvi P; Cozzolino M
    Blood Purif; 2013; 36(1):12-6. PubMed ID: 23736115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease and fragility fracture.
    Kazama JJ
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New Developments in CKD-MBD. Strategies for the management of predilalysis CKD-MBD].
    Ando R
    Clin Calcium; 2014 Dec; 24(12):1845-51. PubMed ID: 25423931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and kidney disease: diagnostic and therapeutic implications.
    Jamal SA; West SL; Miller PD
    Curr Rheumatol Rep; 2012 Jun; 14(3):217-23. PubMed ID: 22350608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New Developments in CKD-MBD. The present state and problem of CKD-MBD treatment in Japan].
    Taniguchi M
    Clin Calcium; 2014 Dec; 24(12):1839-44. PubMed ID: 25423930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 13. [New Developments in CKD-MBD. How to "Thinking Global! Acting Local" for treating CKD-MBD].
    Tsukamoto Y
    Clin Calcium; 2014 Dec; 24(12):1757-61. PubMed ID: 25423919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of CKD-MBD targeting the parathyroid gland].
    Isozaki Y; Komaba H
    Clin Calcium; 2016 Jun; 26(6):895-903. PubMed ID: 27230846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
    Imanishi Y
    Clin Calcium; 2012 Jul; 22(7):1025-33. PubMed ID: 22750935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New Developments in CKD-MBD. Development and progression of CKD-MBD in predialysis period -when and how?].
    Komaba H
    Clin Calcium; 2014 Dec; 24(12):1771-8. PubMed ID: 25423921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis management in patient with renal function impairment.
    Lima GA; Paranhos Neto Fde P; Pereira GR; Gomes CP; Farias ML
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):530-9. PubMed ID: 25166044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone kidney interactions.
    Nickolas TL; Jamal SA
    Rev Endocr Metab Disord; 2015 Jun; 16(2):157-63. PubMed ID: 26156535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease.
    Przedlacki J
    Kidney Int; 2010 Dec; 78(11):1186; author reply 1186. PubMed ID: 21076448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.